Cerinib 150 mg (Ceritinib), general Zykadia is a traditional drug used to treat anaplastic carcinoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) for which cases who are unfit to tolerate or have progressed on previous crizotinib remedy. Cerinib is manufactured by Drug InternationalLtd. in Bangladesh.
Have to take 450 mg orally formerly diurnal with food.
* First cure reduction of 300 mg per day
* Alternate cure reduction 150 mg day
* Unfit to tolerate 150 mg/ day Discontinue
The most common adverse responses are
Diarrhea, nausea, vomiting, abdominal pain, loss of appetite, heartburn, constipation, or frazzle.
The below information comes from the Internet. Please consult with the croaker for medical advice.